financetom
Business
financetom
/
Business
/
Schumer asks DOJ to investigate FTC claim oil exec colluded with OPEC
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Schumer asks DOJ to investigate FTC claim oil exec colluded with OPEC
May 31, 2024 3:54 AM

WASHINGTON (Reuters) -U.S. Senate Majority Leader Chuck Schumer and 22 other Democratic senators on Thursday asked the attorney general to investigate allegations of collusion and price fixing between the oil industry and the Organization of the Petroleum Exporting Countries (OPEC).

Earlier in May, the Federal Trade Commission gave the go-ahead to Exxon Mobil's $60 billion purchase of Pioneer Natural Resources, but barred former Pioneer CEO Scott Sheffield from Exxon's board on allegations he attempted to collude with OPEC to raise oil prices.

"These reports are alarming and lend credence to the fear that corporate avarice is keeping prices artificially high," the senators said in a letter to Attorney General Merrick Garland and his antitrust chief Jonathan Kanter.

"We therefore urge the Department of Justice to investigate the oil industry, to hold accountable any liable actors, and to end any illegal activities," the letter said.

White House Press Secretary Karine Jean-Pierre said she cannot comment on specific cases, and that "the President has made clear that any illegal collusion between big corporations is unacceptable and rips off hardworking families, including if it raises prices at the pump."

Sheffield coordinated efforts with U.S. shale oil producers to constrain their output and raise energy prices, the Federal Trade Commission said on May 2.

Widely considered the dean of U.S. shale because of his long tenure and blunt comments on industry output and spending, Sheffield used his influence "to align oil production across the Permian Basin in West Texas and New Mexico with OPEC+," the FTC added at the time.

A representative for Sheffield's lawyers referred to comments made earlier this week, when Sheffield asked the FTC to dismiss the ban. "At no time did government officials and Mr. Sheffield exchange competitively sensitive information," said Sheffield's counsel Cleary Gottlieb Steen & Hamilton.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved